Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Development of C5a receptor antagonists.

A K Wong1, S M Taylor, D P Fairlie

  • 1Centre for Drug Design and Development, Department of Physiology and Pharmacology, University of Queensland, Brisbane, Queensland 4072, Australia. ddawong@mailbox.uq.oz.au

Idrugs : the Investigational Drugs Journal
|August 30, 2005
PubMed
Summary

Elevated C5a, a potent inflammatory agent, drives disease. New drugs blocking C5a receptors show promise for treating chronic inflammatory disorders linked to complement activation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Systemic delivery of peptides by the oral route: Formulation and medicinal chemistry approaches.

Advanced drug delivery reviews·2020
Same author

A divergent transcriptional landscape underpins the development and functional branching of MAIT cells.

Science immunology·2019
Same author

Mapping transmembrane residues of proteinase activated receptor 2 (PAR<sub>2</sub>) that influence ligand-modulated calcium signaling.

Pharmacological research·2016
Same author

A comparison of peripheral imaging technologies for bone and muscle quantification: a technical review of image acquisition.

Journal of musculoskeletal & neuronal interactions·2016
Same author

Histone deacetylases (HDAC) in physiological and pathological bone remodelling.

Bone·2016
Same author

Product release is rate-limiting for catalytic processing by the Dengue virus protease.

Scientific reports·2016

Area of Science:

  • Immunology
  • Biochemistry

Background:

  • The human complement system is crucial for host defense, initiating inflammatory responses.
  • Elevated levels of C5a, a potent pro-inflammatory anaphylatoxin, are linked to inflammatory diseases.
  • C5a exerts its effects by binding to G-protein-coupled receptors.

Purpose of the Study:

  • To explore the therapeutic potential of inhibiting C5a-receptor interactions.
  • To highlight the development of C5a receptor antagonists for treating inflammatory conditions.

Main Methods:

  • Investigating the role of C5a in inflammatory pathways.
  • Developing antagonists that prevent C5a binding to its receptors.

Main Results:

  • C5a is a key mediator in initiating and developing inflammatory diseases.
  • Blocking C5a-receptor interactions can inhibit pro-inflammatory actions.
  • Significant progress has been made in developing C5a receptor antagonists.

Conclusions:

  • Compounds that prevent C5a binding to its receptors offer a potential treatment strategy.
  • Clinically useful drugs targeting C5a receptors are anticipated in the near future.
  • This research paves the way for novel therapies for complement-driven inflammatory disorders.

Related Experiment Videos